Why the study?
The impact of chronic kidney disease on clinical outcomes after PCI for unprotected left main distal bifurcation lesions is not fully understood in the current generation drug-eluting stent era.
Does chronic kidney disease severity impact clinical outcomes after PCI with current generation drug-eluting stents for unprotected left main distal bifurcation lesions?
Does chronic kidney disease severity impact clinical outcomes after PCI with current generation drug-eluting stents for unprotected left main distal bifurcation lesions?
Answers are grounded in this paper and cite their sources.
Severe chronic kidney disease and hemodialysis are associated with significantly worse clinical outcomes after PCI for unprotected left main distal bifurcation lesions, even with current generation drug-eluting stents.
Objectives. The impact of chronic kidney disease (CKD) on clinical outcomes after percutaneous coronary intervention (PCI) for unprotected left main distal bifurcation lesions (ULMD) is not fully understood in current generation drug eluting stent (cDES) era. We assessed clinical outcomes after PCI using cDES for ULMD according to CKD severity based on estimated glomerular filtration rate (eGFR). Design. We identified 720 consecutive patients who underwent PCI using cDES for ULMD at three high volume centers between January 2005 and December 2015. We divided those patients to the following five groups according to eGFR. Each group was defined as follows: no CKD (60 mL/min/1.73 m² ≤ eGFR), mild CKD (45 ≤ eGFR < 60 mL/min/1.73 m²), moderate CKD (30 ≤ eGFR < 45 mL/min/1.73 m²), severe CKD (15 ≤ eGFR < 30 mL/min/1.73 m²) and hemodialysis (HD). The primary endpoint was target lesion failure (TLF) at 3 years. TLF was defined as a composite of cardiac death, target lesion revascularization (TLR) and myocardial infarction (MI). Results. TLF occurred more frequently in severe CKD and HD group compared with other three groups. Conclusions. The patients who have severe CKD or are on HD, were extremely associated with worse clinical outcomes after PCI for ULMD even with cDES.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: